Customer success

Rutherford Cancer Centres Northumbria and Thames Valley goes live with iQemo

iQ HealthTech are proud to announce another successful iQemo go-live at two more Rutherford Cancer Centres.

Photograph of a chemotherapy ward at a Rutherford Cancer centre.
Photograph of a chemotherapy ward at a Rutherford Cancer centre.

The team at iQ HealthTech are proud to announce another successful iQemo go-live at two more Rutherford Cancer Centres, Northumbria and Thames Valley. The projects were both completed safely, on time and within budget, a testament to the strong working relationship between iQ HealthTech and The Rutherford Cancer Centres that has been built over the last 9 months working together.

Continuing from the work completed at the South Wales site, the project has involved the on-going creation of a comprehensive centralised chemotherapy treatment regimen library, which is shared across all Rutherford Cancer Centre’s. Adding to this the release version of iQemo 1.14.1 at the end of 2018, which offers a range of new functionality including a new streamlined patient scheduling module that is fully integrated with the centre’s patient management system.

The Rutherford Cancer Centre’s are the United Kingdom’s first Proton Beam Therapy treatment providers. iQemo is now live in 3 out of the 4 Rutherford Cancer Centre’s across the United Kingdom, with the fourth centre in Liverpool being opened for treatment later this year.

About iQ HealthTech

iQ HealthTech was established in 2011 by a founding-team of software developers and a practicing consultant oncologist. With a team of subject experts working across design, development, implentations and customer success, the company develops people-centric technology with the goal of improving patient outcomes, everywhere. The company delivers innovative Saas and standalone platforms, including iQemo – the industry-leading, end-to-end chemotherapy prescribing and management platform used by NHS and private hospitals in the UK, and a growing number of hospitals worldwide. Learn more

We’re working on an innovative future for healthcare technology

Sign up to our newsletter and stay updated with industry-leading advice, insight and more…

Thank you! Your submission has been received!
Sorry, something went wrong while submitting the form.

About iQemo

iQemo, from iQHealthTech, provides specialist chemotherapy prescribing. A complete end-to-end solution that includes predefined regimens, prescribing, scheduling and dispensing, through to chemotherapy administration and reporting. iQemo is used in NHS Trusts and private hospitals in the UK, and in a growing number of hospitals worldwide. Learn More

About iQ HealthTech

iQ HealthTech was established in 2011 by a founding-team of software developers and a practicing consultant oncologist. With a team of subject experts working across design, development, implentations and customer success, the company develops people-centric technology with the goal of improving patient outcomes, everywhere. Learn more

Would you like more information about iQemo?

We'd love to discuss how iQemo could support your organisation, people and patients.

Get in touch